High-resolution crystal structure of the anti-CRISPR protein AcrIC5

被引:3
|
作者
Kang, Yong Jun [1 ,2 ]
Park, Hyun Ho [1 ,2 ]
机构
[1] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea
[2] Chung Ang Univ, Grad Sch, Dept Global Innovat Drugs, Seoul 06974, South Korea
基金
新加坡国家研究基金会;
关键词
Anti-CRISPR; AcrIC5; Adaptive immunity; CRISPR-Cas system; Crystal structure; Type I-C cascade; PROVIDES ACQUIRED-RESISTANCE; CAS SURVEILLANCE COMPLEX; STRUCTURE REVEALS; IMMUNE-SYSTEM; INHIBITION; MECHANISMS; BACTERIA; DISCOVERY; PHAGES; GENES;
D O I
10.1016/j.bbrc.2022.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As a result of the long-term battle of bacteria and archaea against invaders such as viruses and genetic mobile elements, they have developed CRISPR-Cas systems for self-defense, which allows them to remove the viral genetic material introduced into host cells via infection. To fight against this bacterial immune system, however, viruses have also evolved to produce multiple anti-CRISPR proteins that can inhibit the bacterial CRISPR-Cas system. In this study, we introduced a tentative inhibitory activity against a type I-C CRISPR-Cas system by determining the crystal structure of AcrIC5 from Pseudomonas delhiensis. Structural analysis revealed that AcrIC5 was composed of noble folds comprising two anti -parallel sheets and three helices. Although AcrIC5 did not directly interact with either the type I-C cascade from Neisseria lactamia or the type I-F cascade from Pseudomonas aeruginosa in our analysis, a highly acidic surface feature indicated that AcrIC5 may be DNA mimic Acrs that directly binds to the target DNA binding site in type I-C cascade and inhibits the recruitment of the target DNA to this cascade.(c) 2022 Elsevier Inc. All rights reserved.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 50 条
  • [11] Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies
    Nicole D. Marino
    Rafael Pinilla-Redondo
    Bálint Csörgő
    Joseph Bondy-Denomy
    [J]. Nature Methods, 2020, 17 : 471 - 479
  • [12] Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein
    Dong, De
    Guo, Minghui
    Wang, Sihan
    Zhu, Yuwei
    Wang, Shuo
    Xiong, Zhi
    Yang, Jianzheng
    Xu, Zengliang
    Huang, Zhiwei
    [J]. NATURE, 2017, 546 (7658) : 436 - +
  • [13] Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies
    Marino, Nicole D.
    Pinilla-Redondo, Rafael
    Csoergo, Balint
    Bondy-Denomy, Joseph
    [J]. NATURE METHODS, 2020, 17 (05) : 471 - 479
  • [14] Structural basis of CRISPR–SpyCas9 inhibition by an anti-CRISPR protein
    De Dong
    Minghui Guo
    Sihan Wang
    Yuwei Zhu
    Shuo Wang
    Zhi Xiong
    Jianzheng Yang
    Zengliang Xu
    Zhiwei Huang
    [J]. Nature, 2017, 546 : 436 - 439
  • [15] Crystal Structure of an Anti-CRISPR Protein, AcrIF2, and its Interaction With Type I-F Cas Proteins
    Ka, Donghyun
    Suh, Nayoung
    Bae, Euiyoung
    [J]. BIOPHYSICAL JOURNAL, 2020, 118 (03) : 39A - 39A
  • [16] Structural Study on Anti-CRISPR Protein AcrVA2
    Chen Peng
    Sun Wei
    Cheng Zhi
    Yang Jing
    Wang Min
    Wang Jiu-Yu
    Chen Hui-Qing
    Liu Liang
    Wang Yan-Li
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2021, 48 (01) : 77 - 87
  • [17] Characterizing the Function of Anti-CRISPR protein ACRIIA11
    del Banco, Serena
    Kaiser, Brett
    Forsberg, Kevin
    Malik, Harmit
    Stoddard, Barry
    [J]. FASEB JOURNAL, 2020, 34
  • [18] ANTI-CRISPR PROTEIN REGULATES CRISPR CAS9 ACTIVITY IN HUMAN EMBRYOS
    Robles, Alex
    Marin, Diego
    Xu, Jian
    Treff, Nathan R.
    Egli, Dieter
    [J]. FERTILITY AND STERILITY, 2022, 118 (04) : E74 - E74
  • [19] HIGH-RESOLUTION STRUCTURE OF A MINI PROTEIN
    KALIA, YN
    BROCKLEHURST, SM
    HIPPS, DS
    APPELLA, E
    SAKAGUCHI, K
    PERHAM, RN
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 276 - 276
  • [20] High-Resolution Crystal Structure of a Lasso Peptide
    Nar, Herbert
    Schmid, Angela
    Puder, Carsten
    Potterat, Olivier
    [J]. CHEMMEDCHEM, 2010, 5 (10) : 1689 - 1692